INTRODUCTION
The number of cancer survivors is growing rapidly and it is anticipated that a large proportion of the expected 20 million individuals will be older than 65 years of age in the coming decade. 1 This "rising tide" of cancer survivors requires more complex care due to increased comorbidity. 2 As such, effective strategies addressing the heterogeneous needs of this growing population, while making efficient use of our healthcare system, are vitally important. 3 Although much progress has been made, particularly over the past decade, there are remaining gaps in the care that cancer survivors receive and questions regarding how to meet the workforce demands and provide optimal care for this expanding population. 4, 5 In the U.S. and abroad, various models are in place that aim to effectively integrate care for cancer survivors into routine clinical care. 6, 7 However, these are highly individualized per setting, are not systematically delivered or evaluated for outcomes, 6 and there is thus no consensus on what, and whether, an optimal model exists or can be developed.
In parallel to growing attention on caring for cancer survivors, an increased focus on integrating palliative care for cancer patients over the past two decades has highlighted potential benefits. [8] [9] [10] However, the field faces significant challenges. As with survivorship care, there is no consensus on the best approach to integrate palliative care into routine practice and readily available, cost-effective, models have not been widely disseminated into clinical settings. [11] [12] [13] Likewise, the increased workforce demands necessitate new delivery models across settings with diverse resources and levels of palliative care expertise. 11, 14, 15 In this commentary, we aim to describe the progress and challenges for both survivorship and palliative care for patients with cancer and offer insights into opportunities to advance the quality of health care delivery in both fields.
Definitions
The terms "survivorship care" and "palliative care" are both associated with uncertainty about who provides the care and what it entails. Survivorship care, while applicable to those living with or beyond cancer, is often restricted in definition to the phase of care following completion of active treatment. 16, 17 Nevertheless, the National Cancer Institute defines a cancer survivor as an individual "from the time of diagnosis, through the balance of his or her life", and includes "family members, friends and caregivers who are impacted by the survivorship experience." 18 Varying use and interpretations of the definitions confuse patients and clinicians alike about what survivorship care truly means. 19 Further, terminology may be problematic as not all patients want to take on the label of "cancer survivor" and its associated advocacy role. 20, 21 Although a survivor is defined from diagnosis forward, in this commentary, we define the period covered by "survivorship care" as the period following primary cancer treatment.
Similarly, palliative care is often confused with end-of-life or terminal care by patients and clinicians, whereas caring for patients very near to the end of life is a small portion of comprehensive palliative care. 12 We define palliative care as care focused on providing patients relief from the symptoms and stress of a serious illness with the goal of improving quality of life for both the patient and the family. 22 To differentiate this area from "survivorship", we focus on those living with advanced, chronic or terminal cancer. The American Society of Clinical Oncology guideline recommends that palliative care begin early in patients' treatment 23 due to clear evidence that palliative care concurrent with traditional oncology treatment offers significant benefits, including extending life itself. 8, 9, 24 However, access to quality palliative care for all patients suffering from advanced cancer remains low and caregivers often feel that it is provided too late. 25, 26 Palliative and survivorship care should acknowledge the confusion, debate and uncertainty in the terminology used in both fields. Clarification and further specification of the phase of care being described or offered is needed in educational, clinical, research and policy discussions. Clinicians must also recognize that patients may have different understanding, preferences and expectations of what palliative and survivorship care are and what they can offer. Both fields may consider how narrowing or broadening their definition may impact their acceptability and reach.
Patient-centered care
A defining and important aspect of both survivorship and palliative care is the impetus to shift from disease-centered to patient-centered care. The Institute of Medicine report entitled "Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis" addressed cancer care across the continuum and emphasized patient-centered care that is "respectful of and responsive to individual patient preferences, needs, and values, and ensuring that patient values guide all clinical decisions." 27 Survivorship care and palliative care both aim to provide patient-centered, supportive care focused on enhancing function, improving the quality of life (QoL) of both patients and caregivers, addressing distress and persistent symptoms such as pain, and encouraging shareddecision making between clinicians and patients. The alignment of patients' personal values to guide clinical decisions is relevant and inherently actualized in palliative care through shared decision making. Engaging patients in decision making may be less emphasized in survivorship care but is still of vital importance since evidence for many interventions, for example, surveillance imaging for recurrences or late effects, is still lacking but often recommended. Factors that may have a significant role in patient-centered care are the duration and intensity of the relationship between the patient and the provider. It is worth noting that both palliative and survivorship care may be longitudinal (typically spanning months to years), survivorship care visits typically occur less frequently as the duration of time since therapy lengthens. Moreover, discussions may focus on restoring or retaining function, and are usually oriented towards achieving long-term goals whereas palliative care visits occur more regularly, discussions may focus on symptoms control and may be oriented toward short-term goals. As an example, while accepted for management of pain in palliative care, long-term management with opioids in cancer survivors is ridden with potential concerns 28 and, even if potentially patient-centered, not desirable. 29, 30 Clearly, there are also important financial as well as insurance-related barriers that must be overcome in both fields. Cancer survivors face significant financial sequalae after diagnosis and, in the United States, cancer-related financial burden has been well documented. 31, 32 In palliative care, insurance coverage and access to hospice services are not universally available, leading to disparities in care quality and delivery. 33 Ensuring that all patients are adequately covered and that healthcare providers are reimbursed for providing survivorship and palliative care services is of critical importance.
Palliative and survivorship care need to continue efforts toward the provision of patientcentered care that takes into account patient preferences and promotes shared decision making. Achieving this goal will require a multi-modal approach that includes provider and patient education, health care delivery, payers and research.
Workforce and training
A large gap between supply and demand in oncology care has been predicted in the coming years in the U.S. and abroad and likely affects the expected gaps in workforce for both palliative and survivorship care. 15, 34, 35 A further complication in this era of demand is the lack of adequate attention to both fields in a majority of clinical curricula. 36, 37 However, in both the U.S. and Europe, palliative care has gained increased official recognition as a subspecialty, indicating that a unique set of skills and knowledge and advanced clinical training are required to practice specialty-level palliative care. 38, 39 In contrast, survivorship care clinicians have no required training and the field has not been recognized as a subspecialty.
Several strategies have been promulgated to combat this gap between supply and demand. These include an increase in the number of working clinicians, further training of advanced practice providers such as nurse practitioners or physicians assistants, and expanding the role of healthcare providers without specialty oncology or palliative care training. 27 Still, both palliative and survivorship care will likely require a multifaceted strategy to grow and prepare the current workforce to meet the increasing demand. 34 Building bridges between disciplines (including primary care) and leveraging the value and expertise of different healthcare professionals is of critical importance to grow and sustain a workforce that is capable of providing quality palliative and survivorship care in the coming years. An increased focus on medical, nursing, and allied health curricula while incorporating training and continuing medical education programs is also essential.
Health care delivery
Oncology providers often feel that they are most suited to continue caring for survivors, and report concerns about primary care-based care for cancer survivors. [40] [41] [42] Patients expect followup visits with oncologists, primarily to detect recurrences, and value consistency and continuity of care. 40, 43 Moreover, patients often do not want to give up the relationship with a provider after sharing such an intense experience and express uncertainty regarding the skills and knowledge of primary care providers about their cancer survivorship needs. 42, 43 The increasing number of cancer survivors and shortage of oncology providers also requires a shift from oncology-based care to models that incorporate other disciplines and professions. 34, 44, 45 For example, a riskstratified approach to identify cancer survivors most in need of direct interventions may be a useful model to provide care based on risk of long-term or late effects and individual needs. 46 This approach could mean that "onco-generalists" (internists with expertise in cancer care) can serve as cancer survivorship experts in addition to engaging both primary care providers and oncologists in providing optimal care for cancer survivors. 45 While early integration of palliative care is now advocated for as the standard of oncology care, healthcare providers still struggle to identify the most optimal model for delivering such care. Whereas palliative care initially provided services via hospice and hospital-based consultation models, the impetus to provide broader and earlier care to more patients is pressuring the expansion of palliative service capabilities. In the U.S., the field has been strategically shifting into the outpatient settings for over a decade. 47 Evidence suggests that efforts to expand delivery of services to the outpatient and home-based palliative care models benefits both patients and families. 48, 49 Further expansion of reach via home-based programs and telemedicine also represent ongoing evolutions of the palliative care model. Similar to survivorship efforts to engage other hybrid providers such as onco-generalists, palliative care is putting significant focus on promoting expertise for advanced practice providers who specialize in oncology to deliver primary palliative care. 22 Importantly, while models address the location of care and reach more patients, there needs to be greater clarity on which services are most helpful across different settings and providers. 11, 49, 50 Although more work is needed, a number of measures evaluating end-of-life quality markers are readily available and have been endorsed by consensus-based entities such as the National Quality Forum. [51] [52] [53] In contrast, quality survivorship care metrics are mostly lacking 4, 54 and the field may draw examples from palliative care through comparable studies using similar, rigorous methodologies. Having such quality markers available is important when moving healthcare towards new, cost-effective models of value based repayment and would also enhance the consistency of care delivery and permit comparison of different models of care across settings. Last, there is a clear need for computer-based clinical decision support to further enhance the quality of care delivery in both fields. Routine integration of easy to use, evidence-based tools within the electronic health record systems is urgently needed. 55
Research
The quality of research in survivorship care has improved in recent years but there are still key gaps that need to be addressed. 56 The Children's Oncology group has led the field in developing guidelines that have been established through high-quality research in the pediatric population. 57, 58 Over the past decade, survivorship-based guidelines have been developed for adult cancers, though evidence for many of the recommendations is still lacking. 4, 54 Most research to date has focused on breast cancer whereas research lags in cancers with similar survival rates. 56 There is also lack of interventional studies, those involving younger and longterm cancer survivors. [58] [59] [60] [61] Further, most studies tend to measure outcomes related to wellbeing and QoL. 59, 61, 62 Although such outcomes are of importance, there is a paucity of studies examining key biologic or genetic components of long-term and late effects of cancer. 56 A multi-faceted understanding of the drivers of chronic and late effects is needed to both identify at-risk patients for intensive follow-up and to tailor specific interventions to address such issues. Another shortcoming is the availability of metrics to measure the quality of survivorship care. 4, 63, 64 Measures such as QoL or well-being may not be sensitive or responsive enough to detect quality differences in survivorship care interventions. 63, 65 On the contrary, palliative care research has been growing and many of the most recent clinically influential studies in the field have been centered around oncological diseases. 66 Although well developed in survivorship care, pediatric palliative care is still very much a growing field and opportunities to further emphasize research in this field remain. [67] [68] [69] International studies have shown various benefits of earlier integration palliative care in terms of QoL, healthcare utilization, levels of patient and caregiver distress, and even survival. 9, 24, 70, 71 As a result, models to introduce earlier palliative care concurrent with standard oncology treatment have received increased recognition. Yet, dissemination of cost-effective and reproducible models remains an important challenge, thus large-scale, randomized trials using predefined quality metrics to demonstrate sustained benefit are needed. Use of novel technologies such as telehealth, as well as dissemination and implementation methodologies would facilitate the scaling of existing proven models and expand testing their effect on different outcomes. 11, 72, 73 To work on such research priorities, both fields need to overcome the institutional and funding barriers currently in place. 56, 74, 75 The Cancer Moonshot initiative to further accelerate cancer research is a much-needed step in the right direction. 76
Opportunities for shared and actionable next steps
Palliative and survivorship care have made important strides, and despite seeming superficially paradoxical, the two fields may have more in common than in opposition. An increased focus on collaboration and a pursuit of shared strategies may foster significant advances in both fields and help patients with and beyond cancer receive high-quality patient-centered care. Figure  1 provides an overview of the similarities and differences between the two fields as well as opportunities for shared and actionable next steps.
In order to achieve these steps, we propose the following: first, both fields need to acknowledge and clarify the existing confusion on terminology through marketing campaigns and education targeted at patients as well as providers. Second, palliative care and survivorship care need to continue collaboratively leading the movement towards the provision of patient-centered care through education and training of providers, engagement of patients and their caregivers, as well as development of systems that incorporate decision tools into direct patient care. Third, expansion and enhancement of a multi-disciplinary workforce is of critical importance, and may be achieved through education, training and involving a broader community of health care providers who may collaboratively care for patients across the continuum of survivorship and palliative care. Fourth, cost-effective models of care delivery need to be identified, tested and implemented. Models should make use of emerging, innovative technologies to deliver care at the point-of-need to patients across different clinical settings. Lastly, there is a clear need for quality metrics to measure the efficacy of these models. Such metrics will allow for consistency of measurement and should be able to both evaluate and identify the quality of care.
Palliative and survivorship care are distinct but yet have shared successes, remaining challenges and opportunities. We hope that an increased focus on collaboration may foster significant advances to both fields and help patients with and beyond cancer receive high-quality, patientcentered care. 
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